p.93 抽出テキスト

610. Godino C, Munafò A, Scotti A, Estevez-Loureiro R, Portoles Hernandez A, Arzamendi D, et al. MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge registry. J Heart Lung Transplant 2020;39:1353–62. https://doi.org/10.1016/j.healun.2020.09.005 611. Ailawadi G, Lim DS, Mack MJ, Trento A, Kar S, Grayburn PA, et al. One-year outcomes after MitraClip for functional mitral regurgitation. Circulation 2019;139:37–47. https:// doi.org/10.1161/CIRCULATIONAHA.117.031733 612. Goel K, Lindenfeld J, Makkar R, Naik H, Atmakuri S, Mahoney P, et al. Transcatheter edge-to-edge repair in 5,000 patients with secondary mitral regurgitation: COAPT post-approval study. J Am Coll Cardiol 2023;82:1281–97. https://doi.org/10.1016/j. jacc.2023.07.015 613. Adamo M, Tomasoni D, Stolz L, Stocker TJ, Pancaldi E, Koell B, et al. Impact of transcatheter edge-to-edge mitral valve repair on guideline-directed medical therapy uptitration. JACC Cardiovasc Interv 2023;16:896–905. https://doi.org/10.1016/j.jcin.2023.01. 362 614. Witte KK, Lipiecki J, Siminiak T, Meredith IT, Malkin CJ, Goldberg SL, et al. The REDUCE FMR trial: a randomized sham-controlled study of percutaneous mitral annuloplasty in functional mitral regurgitation. JACC Heart Fail 2019;7:945–55. https:// doi.org/10.1016/j.jchf.2019.06.011 615. Anker SD, Starling RC, Khan MS, Friede T, Filippatos G, Lindenfeld J, et al. Percutaneous mitral valve annuloplasty in patients with secondary mitral regurgitation and severe left ventricular enlargement. JACC Heart Fail 2021;9:453–62. https://doi.org/ 10.1016/j.jchf.2021.03.002 616. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol 2005;45:381–7. https://doi.org/10.1016/j. jacc.2004.09.073 617. Baldus S, Doenst T, Pfister R, Gummert J, Kessler M, Boekstegers P, et al. Transcatheter repair versus mitral-valve surgery for secondary mitral regurgitation. N Engl J Med 2024;391:1787–98. https://doi.org/10.1056/NEJMoa2408739 618. Acker MA, Parides MK, Perrault LP, Moskowitz AJ, Gelijns AC, Voisine P, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014;370:23–32. https://doi.org/10.1056/NEJMoa1312808 619. von Stumm M, Dudde F, Holst T, Sequeira-Gross T, Pausch J, Muller L, et al. Predicting clinical outcome by indexed mitral valve tenting in functional mitral valve regurgitation. Open Heart 2021;8:e001483. https://doi.org/10.1136/openhrt-2020-001483 620. Girdauskas E, Pausch J, Reichenspurner H, Kempfert J, Kuntze T, Owais T, et al. Subannular repair for functional mitral regurgitation with reduced systolic ventricle function: rationale and design of REFORM-MR registry. J Cardiothorac Surg 2022;17: 343. https://doi.org/10.1186/s13019-022-02045-9 621. Pausch J, Sequeira Gross T, Müller L, von Stumm M, Kloth B, Reichenspurner H, et al. Subannular repair for functional mitral regurgitation type IIIb in patients with ischaemic versus dilated cardiomyopathy. Eur J Cardiothorac Surg 2021;60:122–30. https://doi.org/ 10.1093/ejcts/ezab048 622. Kopjar T, Gasparovic H, Mestres CA, Milicic D, Biocina B. Meta-analysis of concomitant mitral valve repair and coronary artery bypass surgery versus isolated coronary artery bypass surgery in patients with moderate ischaemic mitral regurgitation. Eur J Cardiothorac Surg 2016;50:212–22. https://doi.org/10.1093/ejcts/ezw022 623. Altarabsheh SE, Deo SV, Dunlay SM, Erwin PJ, Obeidat YM, Navale S, et al. Meta-analysis of usefulness of concomitant mitral valve repair or replacement for moderate ischemic mitral regurgitation with coronary artery bypass grafting. Am J Cardiol 2017;119:734–41. https://doi.org/10.1016/j.amjcard.2016.11.024 624. Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 2016;374:1932–41. https://doi.org/10.1056/NEJMoa1602003 625. Vaduganathan M, Docherty KF, Claggett BL, Jhund PS, de Boer RA, Hernandez AF, et al. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet 2022;400:757–67. https://doi.org/10. 1016/S0140-6736(22)01429-5 626. Soulat-Dufour L, Lang S, Addetia K, Ederhy S, Adavane-Scheuble S, Chauvet-Droit M, et al. Restoring sinus rhythm reverses cardiac remodeling and reduces valvular regurgitation in patients with atrial fibrillation. J Am Coll Cardiol 2022;79:951–61. https://doi. org/10.1016/j.jacc.2021.12.029 627. Kagiyama N, Kaneko T, Amano M, Sato Y, Ohno Y, Obokata M, et al. Clinical outcomes of mitral valve surgery in atrial functional mitral regurgitation in the REVEAL-AFMR registry. JAMA Netw Open 2024;7:e2428032. https://doi.org/10.1001/ jamanetworkopen.2024.28032 628. Wagner CM, Brescia AA, Watt TMF, Bergquist C, Rosenbloom LM, Ceniza NN, et al. Surgical strategy and outcomes for atrial functional mitral regurgitation: all functional mitral regurgitation is not the same! J Thorac Cardiovasc Surg 2024;167:647–55. https:// doi.org/10.1016/j.jtcvs.2022.02.056 629. Balogh Z, Mizukami T, Bartunek J, Collet C, Beles M, Albano M, et al. Mitral valve repair of atrial functional mitral regurgitation in heart failure with preserved ejection fraction. J Clin Med 2020;9:3432. https://doi.org/10.3390/jcm9113432 630. Ye Q, Li Y, Zhang W, Zhao Y, Zhao C, Li Z, et al. Catheter ablation or surgical therapy in severe atrial functional mitral regurgitation caused by long-standing persistent atrial fibrillation-propensity score analysis. J Am Heart Assoc 2024;13:e035695. https://doi. org/10.1161/jaha.124.035695 631. Chen J, Wang Y, Lv M, Yang Z, Zhu S, Wei L, et al. Mitral valve repair and surgical ablation for atrial functional mitral regurgitation. Ann Transl Med 2020;8:1420. https://doi. org/10.21037/atm-20-2958 632. Benito-González T, Carrasco-Chinchilla F, Estévez-Loureiro R, Pascual I, Arzamendi D, Garrote-Coloma C, et al. Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation. Int J Cardiol 2021;345: 29–35. https://doi.org/10.1016/j.ijcard.2021.09.056 633. Popolo Rubbio A, Testa L, Grasso C, Sisinni A, Tusa M, Agricola E, et al. Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation: insights from the multi-center MITRA-TUNE registry. Int J Cardiol 2022;349:39–45. https://doi. org/10.1016/j.ijcard.2021.11.027 634. Rudolph F, Geyer M, Baldus S, De Luca VM, Doenst T, Pfister R, et al. Transcatheter repair versus surgery for atrial versus ventricular functional mitral regurgitation: a post hoc analysis of the MATTERHORN trial. Circulation 2024;151:418–20. https://doi.org/ 10.1161/circulationaha.124.072648 635. Tanaka T, Sugiura A, Vogelhuber J, Öztürk C, Böhm L, Wilde N, et al. Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation. EuroIntervention 2024;20:e250–60. https://doi.org/10.4244/eij-d-23-00819 636. Gemelli M, Gallo M, Addonizio M, Van den Eynde J, Pradegan N, Danesi TH, et al. Surgical ablation for atrial fibrillation during mitral valve surgery: a systematic review and meta-analysis of randomized controlled trials. Am J Cardiol 2023;209:104–13. https://doi.org/10.1016/j.amjcard.2023.09.088 637. Suwalski P, Kowalewski M, Jasiński M, Staromlynski J, Zembala M, Widenka K, et al. Survival after surgical ablation for atrial fibrillation in mitral valve surgery: analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK). J Thorac Cardiovasc Surg 2019;157:1007–18.e1004. https://doi.org/10.1016/j.jtcvs. 2018.07.099 638. Hamada S, Ueyama H, Aikawa T, Kampaktsis PN, Misumida N, Takagi H, et al. Outcomes of transcatheter edge-to-edge repair for atrial functional mitral regurgitation: a meta-analysis of observational studies. Catheter Cardiovasc Interv 2023;102: 751–60. https://doi.org/10.1002/ccd.30806 639. Sodhi N, Asch FM, Ruf T, Petrescu A, von Bardeleben S, Lim DS, et al. Clinical outcomes with transcatheter edge-to-edge repair in atrial functional MR from the EXPAND study. JACC Cardiovasc Interv 2022;15:1723–30. https://doi.org/10.1016/j. jcin.2022.07.023 640. Deja MA, Grayburn PA, Sun B, Rao V, She L, Krejca M, et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 2012;125:2639–48. https://doi.org/10.1161/CIRCULATIONAHA.111. 072256 641. Chan KM, Punjabi PP, Flather M, Wage R, Symmonds K, Roussin I, et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation 2012;126:2502–10. https://doi.org/10.1161/ circulationaha.112.143818 642. Virk SA, Tian DH, Sriravindrarajah A, Dunn D, Wolfenden HD, Suri RM, et al. Mitral valve surgery and coronary artery bypass grafting for moderate-to-severe ischemic mitral regurgitation: meta-analysis of clinical and echocardiographic outcomes. J Thorac Cardiovasc Surg 2017;154:127–36. https://doi.org/10.1016/j.jtcvs. 2017.03.039 643. Adamo M, Fiorelli F, Melica B, D’Ortona R, Lupi L, Giannini C, et al. COAPT-like profile predicts long-term outcomes in patients with secondary mitral regurgitation undergoing MitraClip implantation. JACC Cardiovasc Interv 2021;14:15–25. https://doi.org/10. 1016/J.JCIN.2020.09.050 644. Coffey S, Roberts-Thomson R, Brown A, Carapetis J, Chen M, Enriquez-Sarano M, et al. Global epidemiology of valvular heart disease. Nat Rev Cardiol 2021;18:853–64. https://doi.org/10.1038/s41569-021-00570-z 645. Kingue S, Ba SA, Balde D, Diarra MB, Anzouan-Kacou JB, Anisubia B, et al. The VALVAFRIC study: a registry of rheumatic heart disease in Western and Central Africa. Arch Cardiovasc Dis 2016;109:321–9. https://doi.org/10.1016/j.acvd.2015. 12.004 646. Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D, et al. European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J 2022;43: 716–99. https://doi.org/10.1093/eurheartj/ehab892 647. Churchill TW, Yucel E, Deferm S, Levine RA, Hung J, Bertrand PB. Mitral valve dysfunction in patients with annular calcification: JACC review topic of the week. J Am Coll Cardiol 2022;80:739–51. https://doi.org/10.1016/j.jacc.2022.05.032 648. Andell P, Li X, Martinsson A, Andersson C, Stagmo M, Zoller B, et al. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study. Heart 2017;103:1696–703. https://doi.org/10.1136/heartjnl-2016-310894 649. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1–23; quiz 101–102. https://doi.org/10. 1016/j.echo.2008.11.029

ESC Guidelines                                                                                                                                                                                          4727

Downloaded from academic.oup.com/eurheartj/article/46/44/4635/8234488 by guest on 07 October 2026